Literature DB >> 16641791

Benign liver masses: imaging with microbubble contrast agents.

Tae Kyoung Kim1, Hyun-Jung Jang, Stephanie R Wilson.   

Abstract

Benign focal liver lesions are frequently encountered in routine ultrasound (US) scanning as well as in staging US examination for the patients with known malignancy. Noninvasive characterization of benign liver masses by imaging features has been a challenge for the radiologist. Some benign liver masses show typical findings on US; however, these findings are not highly specific. Contrast-enhanced ultrasound (CEUS) is useful to make an instant, confident diagnosis of benign liver masses. Contrast-enhanced multiphasic computed tomography (CT) is an excellent imaging technique to detect and characterize focal liver masses. But there are a considerable number of indeterminate focal liver lesions, which require further evaluation. CEUS provides the evaluation of perfusion and hemodynamics of nodular liver lesions as well as real-time morphologic evaluation of lesion vascularity. Most benign liver masses show characteristic features on CEUS, allowing an accurate diagnosis. This review article describes typical enhancement features of common benign liver masses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641791

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  9 in total

Review 1.  Evaluation of hepatic cystic lesions.

Authors:  Marten A Lantinga; Tom J G Gevers; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

Review 2.  Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions.

Authors:  Stanislas-H Morin; Adrian-Kp Lim; Jeremy-Fl Cobbold; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

3.  Evaluation of neovascularization with spectral computed tomography in a rabbit VX2 liver model: a comparison with real-time contrast-enhanced ultrasound and molecular biological findings.

Authors:  Yue Zhou; Jian-Bo Gao; Han Xu; Jun-Qiang Dong; Ming-Yue Wang
Journal:  Br J Radiol       Date:  2015       Impact factor: 3.039

Review 4.  Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis.

Authors:  Tae Kyoung Kim; Hyun-Jung Jang
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 5.  Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.

Authors:  Tae Kyoung Kim; Seung Yeon Noh; Stephanie R Wilson; Yuko Kono; Fabio Piscaglia; Hyun-Jung Jang; Andrej Lyshchik; Christoph F Dietrich; Juergen K Willmann; Alexander Vezeridis; Claude B Sirlin
Journal:  Clin Mol Hepatol       Date:  2017-09-15

Review 6.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07

Review 7.  Contrast-enhanced ultrasound in the detection and characterization of liver tumors.

Authors:  Hyun-Jung Jang; Hojun Yu; Tae Kyoung Kim
Journal:  Cancer Imaging       Date:  2009-11-06       Impact factor: 3.909

Review 8.  Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.

Authors:  Jae Young Jang; Moon Young Kim; Soung Won Jeong; Tae Yeob Kim; Seung Up Kim; Sae Hwan Lee; Ki Tae Suk; Soo Young Park; Hyun Young Woo; Sang Gyune Kim; Jeong Heo; Soon Koo Baik; Hong Soo Kim; Won Young Tak
Journal:  Clin Mol Hepatol       Date:  2013-03-25

Review 9.  Imaging findings of mimickers of hepatocellular carcinoma.

Authors:  Tae Kyoung Kim; Eunchae Lee; Hyun-Jung Jang
Journal:  Clin Mol Hepatol       Date:  2015-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.